首页> 外国专利> GINGIVAL HYPERTROPHY INHIBITOR

GINGIVAL HYPERTROPHY INHIBITOR

机译:牙龈肥大抑制剂

摘要

PROBLEM TO BE SOLVED: To provide an excellent gingival hypertrophy inhibitor.;SOLUTION: This gingival hypertrophy inhibitor contains a compound having angiotensin II antagonism, its prodrug or its salt. The compound having the angiotensin II antagonism preferably comprises a compound expressed by formula (I) [R1 is an anion-formable group or a group which can be changed into the anion-formable group; X is a linkage which joins the phenylene and the phenyl directly or through a spacer comprising two or less atomic chains; A is a benzene ring which may be further substituted; R2 is an anion-formable group or a group which can be changed into the anion-formable group; R3 is a hydrocarbon residue which may be bonded through a hetero atom or may be substituted; and n is 1 or 2] and more preferably comprises Losartan, Eprosartan, Candesartan cilexetil, Candesartan, Valsartan, Telmisartan, Irbesartan, Olmesartan or Tasosartan.;COPYRIGHT: (C)2002,JPO
机译:解决的问题:提供一种优异的牙龈肥大抑制剂。解决方案:该牙龈肥大抑制剂包含具有血管紧张素II拮抗作用的化合物,其前药或其盐。具有血管紧张素II拮抗作用的化合物优选包含由式(I)表示的化合物。[R1为可形成阴离子的基团或可转变为可形成阴离子的基团; X是直接或通过包含两个或更少原子链的间隔基连接亚苯基和苯基的键; A是可以被进一步取代的苯环; R 2为可形成阴离子的基团或可被改变为可形成阴离子的基团的基团; R3是可通过杂原子键合或可被取代的烃基; [n为1或2],更优选为氯沙坦,依普罗沙坦,坎地沙坦酯,坎地沙坦,缬沙坦,替米沙坦,厄贝沙坦,奥美沙坦或塔索沙坦。;版权:(C)2002,JPO

著录项

  • 公开/公告号JP2002212101A

    专利类型

  • 公开/公告日2002-07-31

    原文格式PDF

  • 申请/专利权人 TAKEDA CHEM IND LTD;

    申请/专利号JP20010011650

  • 发明设计人 MURAKAMI HAJIME;

    申请日2001-01-19

  • 分类号A61K45/00;A61K31/41;A61K31/4178;A61K31/4184;A61K31/4245;A61K31/522;A61P1/02;A61P43/00;

  • 国家 JP

  • 入库时间 2022-08-22 00:56:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号